Walleye Trading LLC Crispr Therapeutics Ag Put Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Put Options

25 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$44.62 - $62.75 $343,574 - $483,175
7,700 Added 78.57%
17,500 $822,000
Q2 2024

Aug 14, 2024
SELL
$51.17 - $68.18 $1.41 Million - $1.88 Million
-27,600 Reduced 73.8%
9,800 $529,000
Q1 2024

May 15, 2024
SELL
$60.67 - $89.12 $4.6 Million - $6.76 Million
-75,900 Reduced 66.99%
37,400 $2.55 Million
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $2.49 Million - $4.65 Million
64,400 Added 131.7%
113,300 $7.09 Million
Q3 2023

Nov 14, 2023
BUY
$45.39 - $59.0 $267,801 - $348,100
5,900 Added 13.72%
48,900 $2.22 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $8.65 Million - $13.5 Million
-198,900 Reduced 82.22%
43,000 $2.41 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $5.29 Million - $7.25 Million
129,100 Added 114.45%
241,900 $10.9 Million
Q4 2022

Feb 14, 2023
SELL
$39.19 - $65.67 $2.01 Million - $3.37 Million
-51,300 Reduced 31.26%
112,800 $4.59 Million
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $30,550 - $41,890
-500 Reduced 0.3%
164,100 $10.7 Million
Q2 2022

Aug 08, 2022
BUY
$43.23 - $73.83 $2.93 Million - $5.01 Million
67,800 Added 70.04%
164,600 $10 Million
Q1 2022

May 16, 2022
BUY
$53.19 - $79.24 $4.16 Million - $6.2 Million
78,300 Added 423.24%
96,800 $6.08 Million
Q4 2021

Feb 14, 2022
SELL
$70.09 - $111.29 $42,054 - $66,774
-600 Reduced 3.14%
18,500 $1.4 Million
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $253,460 - $360,271
2,300 Added 13.69%
19,100 $2.14 Million
Q2 2021

Aug 16, 2021
BUY
$100.84 - $161.89 $695,796 - $1.12 Million
6,900 Added 69.7%
16,800 $2.72 Million
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $409,664 - $777,148
3,700 Added 59.68%
9,900 $1.21 Million
Q4 2020

Feb 16, 2021
BUY
$79.67 - $173.23 $470,053 - $1.02 Million
5,900 Added 1966.67%
6,200 $949,000
Q3 2020

Nov 16, 2020
SELL
$78.5 - $100.64 $78,500 - $100,640
-1,000 Reduced 76.92%
300 $25,000
Q2 2020

Aug 14, 2020
SELL
$38.5 - $76.05 $192,500 - $380,250
-5,000 Reduced 79.37%
1,300 $96,000
Q1 2020

May 15, 2020
SELL
$33.68 - $62.53 $1.63 Million - $3.02 Million
-48,300 Reduced 88.46%
6,300 $267,000
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $396,144 - $789,804
10,800 Added 24.66%
54,600 $3.33 Million
Q3 2019

Nov 14, 2019
BUY
$40.99 - $52.56 $1.77 Million - $2.28 Million
43,300 Added 8660.0%
43,800 $1.8 Million
Q2 2019

Aug 14, 2019
SELL
$35.45 - $48.2 $329,685 - $448,260
-9,300 Reduced 94.9%
500 $24,000
Q1 2019

May 15, 2019
SELL
$28.02 - $40.87 $439,914 - $641,659
-15,700 Reduced 61.57%
9,800 $350,000
Q4 2018

Feb 14, 2019
BUY
$22.73 - $42.34 $565,977 - $1.05 Million
24,900 Added 4150.0%
25,500 $729,000
Q3 2018

Nov 14, 2018
BUY
$44.35 - $65.71 $26,610 - $39,425
600 New
600 $27,000

Others Institutions Holding CRSP

# of Institutions
491
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email